Patients older than 75 years also benefit from kidney transplantation

People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases. Screening programs have increased the survival rates of many illnesses such as cancer, national vaccination programs have completely eradicated many diseases, and better safety standards such as traffic regulation, risk management and safe work procedures have helped to reduce the number of accidents.

In a nutshell, people are getting older and healthier, but the prevention of chronic kidney disease (CKD) is lagging behind, with the number of patients on the rise. In 2016, 121 pmp started renal replacement, in 2017 this number rose to 127 pmp - according to figures released by the ERA-EDTA Renal Registry. Most patients are elderly people, because the risk of chronic kidney disease increases with age. The mean age of patients starting RRT was 63.4 years.

The best available treatment of end-stage renal disease is kidney transplantation.

We know that patients benefit immensely from this treatment, survival and quality of life are significantly better compared to dialysis patients."

Professor Ron Gansevoort, Press Officer of the ERA-EDTA

This can be easily explained: After successful kidney transplantation, the detoxification function can return almost completely to normal, and there is no accumulation of toxins and water in the body, as in dialysis patients between dialysis treatments. Furthermore, patients are not dependent on the blood washing procedure (usually 3 times a week for 4 hour), which greatly impacts "normal life".

However, due to the scarcity of donor organs, which is dramatic in many European countries, it is not possible for large numbers of people to receive transplants. When it comes to elderly patients, this scarcity produces a moral dilemma. Would it be correct to implant an organ into an elderly patient when a younger patient is also waiting for an organ and has a much longer life span ahead of him/her? One solution is the "old-to-old" donation, in which elderly patients receive the organs of deceased elderly patients. This raises the questions as to whether this kind of transplantation was "worth" being done, e.g. whether the old organs would work properly and whether the transplanted patient would derive a significant benefit.

These questions have now been answered by a new study published in NDT. 138 recipients (>75 years) who received kidney transplants from similarly aged deceased persons between 2002 and 2015 were analyzed. One- and five-year patient survival was 82.1% and 60.1%, respectively, whereas the corresponding rates for death-censored graft survival were 95.6% and 93.1%, respectively.

"This study showed that elderly patients do indeed benefit from kidney transplantation, even when the donor organ is also old. Graft survival was found to be excellent, with nearly all patients remaining dialysis-free for the rest of their lives. In that light, we may have to reconsider our recommendation. We always thought that transplantation should generally not be offered to the very elderly (>75 years) because of the perioperative risks. The present study suggests otherwise. Larger studies that also take quality of life, number of hospital admissions and duration of hospital stays into account are also needed, however", concludes Professor Gansevoort.

Source:
Journal reference:

Cabrera, J., et al. (2020) Kidney transplantation in the extremely elderly from extremely aged deceased donors: a kidney for each age. Nephrology Dialysis Transplantation. doi.org/10.1093/ndt/gfz293.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients